$65.50
0.14[0.21%]
At close: Apr 29
$65.50
0[0.00%]
After Hours: 4:20PM EDT
ANI Pharmaceuticals
(NASDAQ:ANIP)Latest News for ANI Pharmaceuticals Stock (NASDAQ:ANIP)
ANI Pharmaceuticals Stock (NASDAQ: ANIP)
Categories: All
Thursday, April 25, 2024
Tuesday, April 23, 2024
Thursday, April 11, 2024
Tuesday, April 09, 2024
Wednesday, March 27, 2024
Friday, March 15, 2024
Tuesday, March 12, 2024
Monday, March 11, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
- ANI Pharmaceuticals Forecasts 2024 Adjusted EBITDA Of $135M-$145MBenzinga Newsdesk - Feb 29, 2024, 6:57AM
- ANI Pharmaceuticals Forecasts 2024 Purified Cortrophin Gel Revenues Of $170M-$180M, Up 52%-61%Benzinga Newsdesk - Feb 29, 2024, 6:56AM
- ANI Pharmaceuticals Forecasts 2024 Revenues Of $520M-$542M, With Adjusted EPS Of $4.26 to $4.67 Versus Consensus Of $506.16M And $4.33, RespectivelyBenzinga Newsdesk - Feb 29, 2024, 6:54AM
- ANI Pharmaceuticals Q4 Adjusted EPS $1.00 Beats $0.85 Estimate, Sales $131.65M Beat $122.21M EstimateBenzinga Newsdesk - Feb 29, 2024, 6:52AM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Friday, February 16, 2024
Tuesday, January 23, 2024
Tuesday, January 16, 2024
Friday, November 17, 2023
Wednesday, November 08, 2023
- Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?Vandana Singh - Nov 8, 2023, 2:14PM
- ANI Pharmaceuticals shares are trading lower despite the company reporting a Q3 earnings beat and raising guidance.Benzinga Newsdesk - Nov 8, 2023, 11:20AM
- CORRECTION: ANI Pharmaceuticals Sees FY23 Adj. EPS of $4.29-$4.57 Versus Prior Guidance Of $3.62-$4.11 And Consensus of $4.08Benzinga Newsdesk - Nov 8, 2023, 9:25AM
- ANI Pharmaceuticals Sees FY23 Adj. EPS of $4.29-$4.57 Versus Prior Guidance Of $3.62-$4.11 And Consensus of $4.08Benzinga Newsdesk - Nov 8, 2023, 6:58AM
- ANI Pharmaceuticals Sees FY23 Revenue of $468M-$478M Versus Prior Guidance Of $425M-$445M And Consensus of $452.94MBenzinga Newsdesk - Nov 8, 2023, 6:57AM
- ANI Pharmaceuticals Q3 Adjusted EPS $1.27 Beats $0.84 Estimate, Sales $131.83M Beat $111.92M EstimateBenzinga Newsdesk - Nov 8, 2023, 6:52AM
- Earnings Scheduled For November 8, 2023Benzinga Insights - Nov 8, 2023, 4:21AM
Thursday, October 19, 2023
Wednesday, September 13, 2023
Tuesday, September 12, 2023
Tuesday, August 22, 2023
Monday, August 21, 2023
Thursday, August 10, 2023
Wednesday, August 09, 2023
- ANI Pharmaceuticals Raises FY23 Adjusted non-GAAP EPS Guidance To $3.62-$4.11 From $2.99-$3.45, Vs. Consensus Of $3.31Benzinga Newsdesk - Aug 9, 2023, 6:58AM
- ANI Pharmaceuticals Raises FY23 Net Revenue Guidance To $425M-$445M From $385M-$410M, Vs. Consensus Of $406.41MBenzinga Newsdesk - Aug 9, 2023, 6:55AM
- ANI Pharmaceuticals Q2 Adj. EPS $1.28 Beats $0.68 Estimate, Sales $116.55M Beat $98.70M EstimateBenzinga Newsdesk - Aug 9, 2023, 6:52AM
- Earnings Scheduled For August 9, 2023Benzinga Insights - Aug 9, 2023, 4:54AM